Human mucosal proteins

Human mucosal proteins represent a broad and heterogeneous category of proteins found within the mucosal layers of the respiratory, gastrointestinal, and urogenital tracts. This group includes structural glycoproteins known as mucins (e.g., MUC2, MUC5AC), which are essential for forming the protective gel-like barrier that lubricates epithelial surfaces and traps inhaled or ingested pathogens (Source: NCBI, "Mucins in Cancer"). Beyond structural roles, this category encompasses functional proteins such as secretory IgA, lysozyme, and defensins, which provide a critical first line of immune defense against infection (Source: PubMed, "Mucosal Immunity"). In diseases like cystic fibrosis and chronic obstructive pulmonary disease (COPD), the dysregulation or hypersecretion of these proteins leads to pathological mucus thickening and airway obstruction (Source: StatPearls, "Cystic Fibrosis"). Conversely, a breakdown in the mucosal protein barrier is a hallmark of inflammatory bowel disease (IBD), where increased permeability allows for bacterial translocation and chronic inflammation (Source: Nature Reviews, "The Mucosal Barrier"). Because this term refers to a collective proteome rather than a single molecular entity, it is considered too broad to be a specific therapeutic target, although individual proteins within this group are frequently targeted by mucolytics and anti-inflammatory drugs.

Other names

Mucosal proteomeMucus-associated proteinsEpithelial surface proteinsMucosal barrier proteins

Mucolytic agents like N-acetylcysteine act by reducing the disulfide bonds between mucin monomers, thereby decreasing the viscosity of the mucus (Source: StatPearls, "Mucolytics"). Other agents like dornase alfa function by enzymatically cleaving extracellular DNA present in the mucus of cystic fibrosis patients to improve clearance (Source: PubMed, "Dornase alfa in CF").